24/7 Market News Snapshot 14 October, 2024 – INVO BioScience,INC Common Stock (NASDAQ:INVO)

October 14, 2024

DENVER, Colo., 14 October, 2024 (247marketnews.com) – (NASDAQ:INVO) are discussed in this article.
INVO BioScience, Inc. has made headlines with its recent strategic moves, including a notable surge in stock value and the successful completion of a transformative merger with NAYA Biosciences. As the market responded positively to these developments, INVO’s stock opened at $0.67 and soared to an impressive $1.037, marking an increase of over 58.32% as trading volume reached 3.23 million shares. This significant price uptick reflects growing investor confidence in INVO’s business outlook.

The merger with NAYA Biosciences positions the newly formed entity to enhance patient access to innovative therapeutics aimed at oncology and autoimmune diseases. Following the merger, the company will rebrand as NAYA Biosciences and trade under the ticker symbol “NAYA” on NASDAQ. This union effectively aligns INVO’s established revenue-generating fertility operations with NAYA’s comprehensive pipeline of clinical-stage assets, amplifying the combined organization’s growth potential.

The leadership team will consist of seasoned executives from both companies, with INVO’s CEO Steve Shum and CFO Andrea Goren, alongside Dr. Daniel Teper, the former CEO of NAYA, who will now serve as the President of the combined company and Chief Executive Officer of the NAYA Therapeutics subsidiary. Dr. Teper’s considerable expertise in biopharma, paired with the synergies from the merger, aims to optimize the risk-return profile and expedite product development cycles.

Prominent projects include advancing NAYA’s lead GPC3-targeting FLEX-NK™ bispecific antibody, poised to commence Phase I/II trials. This collaboration represents a promising evolution within the healthcare sector, enhancing treatment options and reinforcing INVO’s commitment to delivering innovative solutions across its spectrum of business endeavors.

Related news for (INVO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.